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Abstract
Glucagon hormone is synthesized and released by pancreatic a-cells, one of the islet-cell types. This hormone, along with
insulin, maintains blood glucose levels within the physiological range. Glucose stimulates glucagon release at low
concentrations (hypoglycemia). However, the mechanisms involved in this secretion are still not completely clear. Here,
using experimental calcium time series obtained in mouse pancreatic islets at low and high glucose conditions, we propose
a glucagon secretion model for a-cells. Our model takes into account that the resupply of releasable granules is not only
controlled by cytoplasmic Ca2z, as in other neuroendocrine and endocrine cells, but also by the level of extracellular
glucose. We found that, although calcium oscillations are highly variable, the average secretion rates predicted by the
model fall into the range of values reported in the literature, for both stimulated and non-stimulated conditions. For low
glucose levels, the model predicts that there would be a well-controlled number of releasable granules refilled slowly from a
large reserve pool, probably to ensure a secretion rate that could last for several minutes. Studying the a-cell response to
the addition of insulin at low glucose, we observe that the presence of insulin reduces glucagon release by decreasing the
islet Ca2z level. This observation is in line with previous work reporting that Ca2z dynamics, mainly frequency, is altered by
insulin [1]. Thus, the present results emphasize the main role played by Ca2z and glucose in the control of glucagon
secretion by a-cells. Our modeling approach also shows that calcium oscillations potentiate glucagon secretion as
compared to constant levels of this cellular messenger. Altogether, the model sheds new light on the subcellular
mechanisms involved in a-cell exocytosis, and provides a quantitative predictive tool for studying glucagon secretion
modulators in physiological and pathological conditions.
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Introduction
Pancreatic islets of Langerhans, which play a crucial role in
glucose homeostasis, are mainly formed by three types of
exocytotic cells (a , b and d). a-cells represent 15 to 20% of islet
cells and secrete glucagon in response to decreased blood glucose
levels. Glucagon in turn stimulates glucose production by the liver.
In contrast, insulin is secreted by pancreatic b-cells when plasma
glucose concentrations are elevated, leading to the insulin-
dependent glucose uptake by peripheral tissues. Impaired
glucagon secretion has been associated to hyperglycaemic periods
in diabetic patients. Despite their importance, a-cells are much less
studied than b-cells most probably because of several technical
limitations [2]. More surprisingly, as far as we know, there is no
modeling study devoted to the molecular mechanisms regulating
glucagon secretion by this cell type, although we have reported a
modeling study of electrical currents related to glucagon secretion
[3]. In contrast, there have been several theoretical works devoted
to the secretion of insulin by pancreatic b-cells (for example [4–6]).
Experimentally, measurements of glucagon secretion are
commonly obtained by incubating pancreatic islets in media with
low glucose concentrations for several minutes. Under low-glucose
levels (stimulated), the total amount of secreted glucagon in mice
ranges from 30 to 40 picograms per islet (pg/islet) in one hour, and
this amount is approximately twice the basal (non-stimulated)
secretion that is seen at the high glucose concentrations typically
used in these experiments [7–10]. These quantities are inferred
from measurements of the accumulated glucagon for a one hour
period from a large number of islets, each mouse islet containing
on average, 400+200 a-cells [2]. Such an stimulated glucagon
secretion could be produced by a constant rate between 0.5 and
1 pg/islet (or fF) per minute, as reported in one experimental work
[7].
Glucagon is released by a-cells through the Ca2z -dependent
exocytosis of secretory granules. The mechanism responsible for
the modulation of intracellular Ca2z by extracellular glucose
levels is still a matter of debate and has been ascribed either to a
direct glucose effect, or to a paracrine effect involving b-cells [11].
The direct effect could be managed by the KATP channels present
in a-cells which are glucose-sensitive [10], or by a glucose-induced
alteration of Ca2z -storing mechanisms [9]. Although the signal-
transduction pathway relating low glucose levels to Ca2z increase
remains to be further clarified, these Ca2z rises have been well
characterized. Opposite to what happens in b-cells, that all of
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with high glucose levels [12], about 30% of the total islet a-cells
exhibit oscillations when exposed to low-glucose levels [13]. These
oscillations are asynchronous and highly irregular. Oscillation
frequency can go from 0.1 to 0.7 per minute at 3 mM glucose
[12,14,15], up to 0.5 to 1 per minute at 0.5 mM glucose [16]. The
amplitude of these oscillations runs from basal Ca2z levels (near
100 nM) up to two to five times this value [13,14,17]. This
spontaneous behaviour has been widely observed in isolated a-cells
[13,14], in clonal cell lines [16,18], and in intact islets [12].
Exocytosis by a-cells in response to electrical stimulation hasbeen
well characterized. In these experiments, the secretory response is
inferred from the associated increments in cell membrane
capacitance due to granule fusion [7,10,19–21]. In contrast, there
are few reports of experiments performed on islets, or on isolated a-
cells, that relate Ca2z oscillations induced by low glucose
concentrations to glucagon release, in the presence of various
pharmacological modulators [8,13,15]. Both stimulatory protocols
(electrical or low-glucose), however, induce highly different levels of
secretion. Under electrical protocols, the release evoked by a
millisecond depolarization reaches rates up to 150 granules per
second [20], whereas the secretion rates attained under low-glucose
stimulation are in the order of 0.5 granules per minute, equal to 1 fF
per minute considering an increase of membrane capacitance of 2
fF per granule as stated in [19]. Moreover, experimental data about
dynamic secretion rates under low-glucose stimulation are scarce
[7]. Therefore, there is a clear need to explore glucagon secretion
dynamics using modeling techniques.
In this work, we propose a secretion model for a-cells based on
experimental data of Ca2z recorded in intact islets, in response to
low and high glucose. As the signaling pathway linking the level of
glucose and the concentration of intracellular Ca2z remains
unclear, it is not considered explicitly in the model. Instead, the
different glucose concentrations are taken into account in the model
by different Ca2z oscillatory patterns obtained experimentally at
these glucose concentrations. Such Ca2z time series are taken as
input to the simulations, and they feed our model for Ca2z -
mediated secretion. Our model incorporates that the resupply of
releasable granules is not only controlled by cytoplasmic Ca2z ,a s
in other neuroendocrine and endocrine cells [22,23], but also by the
level of extracellular glucose. The output of the model, i.e. the
amount of glucagon secreted, is compared to secretion levels
induced by the same glucose concentrations, which have been
measured in our laboratory and/or are available in the literature.
Wehavealsoobtaineda-cellCa2z recordsinthe presenceofinsulin
at low glucose, and used the model to predict the effect of this
hormone on glucagon secretion.
Methods
Experiments
All protocols were conducted following the regulations ap-
proved by the Animal Care Committee of the Universidad Miguel
Herna ´ndez (approval ID: IB-IQM-001-10), according to national
and European policies about ethics in animal research. Swiss
albino OF1 mice (8–10 weeks old) were sacrificed by cervical
dislocation and pancreatic islets were then isolated by collagenase
digestion as previously described [8]. Single islets were loaded with
5 mM of the acetoxymethyl form of the Ca2z probe Fluo-4
(Molecular Probes; Leiden, The Netherlands) for at least 1 hour at
room temperature in a medium containing (mM): NaCl, 115;
NaHCO3, 10; KCl, 5; MgCl2, 1.1; NaH2PO4, 1.2; CaCl2, 2.5;
HEPES, 25; bovine serum albumin, 1%; D-glucose, 5 mM,
pH=7.4. All experiments were carried out at 370C.
For imaging experiments, islets were placed on a perfusion
chamber mounted on the microscope stage and attached onto
poly-L-lysine treated coverslips for 10 min before commencing the
experiments. Islets were then perfused at a rate of 1.5 ml/min with
a modified Ringer solution containing (mM): 120 NaCl, 5 KCl, 25
NaHCO3, 1.1 MgCl2 and 2.5 CaCl2; pH 7.4, gassed with 95%
O2 and 5% CO2. Ca2z signals were monitored in individual cells
within the islets using a Zeiss LSM 510 laser confocal microscope
equipped with a 406 oil immersion objective (numerical
aperture=1.3). The system configuration was set to excite the
Ca2z probe at 488 nm and collect the emission with a bandpass
filter at 505–530 nm from an optical section of 8 mm. Images
were collected at 2 s intervals. Temporal series were treated with a
low pass filter and processed using the digital image software of the
confocal microscope. Pancreatic a-cells were functionally identi-
fied by their characteristic oscillatory Ca2z signal at 0.5 mM
glucose [8,12,24]. Calcium oscillations were recorded for 10 min-
utes at 0.5 mM glucose (0:5G), which stimulate a cells, followed by
a subsequent period of 15 minutes at 11 mM glucose (11G) which
inhibits the oscillatory calcium activity in these cells.
Following these methods, 2 different sets of Ca2z data were
obtained. The first set is made of 14 Ca2z oscillation traces, lasting
25 minutes. These 25-minute records consist of 10 minutes at 0.5 mM
glucose (0:5G), which stimulate a-cells, followed by 15 minutes at
11 mM glucose (11G), which inhibits the oscillatory calcium activity in
these cells. The second set is composed by 23 Ca2z oscillation traces,
lasting 16 minutes (6 min at 0:5G followed by 10 min at 0:5G+4n M
insulin). In both sets each record corresponds to a single a-cell found in
the first layer of an islet, and cells were issued from three islets for each
set. In Figure 1,some examplesof the recorded Ca2z oscillations ofthe
first set are shown. Note that the first five minutes at 11G correspond to
a transition period in which glucose levels are changing in the bath, so
they are not used for the modeling work.
Model description
The kinetic model for glucagon secretion, which describes Ca2z
-triggered exocytosis in a-cells, is schematized in Figure 2. It is
based on previously developed models describing secretion in
chromaffin cells [25] and in pancreatic b-cells [5], and it has been
adapted to take into account observed specificities of pancreatic a-
cells. Two types of secretory granules are considered in the model.
The first type constitutes the so-called ‘reserve pool’ (pool R)
located in the cytoplasm. These granules are susceptible to be
mobilized towards the membrane and to undergo a maturation
process. These transformations are called ‘docking’ and ‘priming’,
respectively, and are grouped in a single step in the model. After
this transition, granules are ‘ready to be released’ and are named
‘primed’ granules (pool P). In addition, Pi stands for the pool of
primed granules bound to iC a 2z ions, and F is the pool of fused
granules. Usually, fusion to the membrane and secretion occur in
response to a considerable Ca2z increase in the microdomain
located just below the plasma membrane [22]. Therefore, we
consider that 3 Ca2z ions are necessary to trigger granule fusion,
similarly to what has been suggested for b-cells [5,6].
The variables of the model are the number of granules in each of
the 6 states schematized in Figure 2. Transition from the reserve
pool to the primed pool is supposed to be a reversible process.
Priming is supposed to be activated by cytosolic Ca2z as in other
cell types [5,25]. Specific to a-cells is the fact that resupply is also
somehow sensitive to the extracellular glucose level, independently
from Ca2z . It has indeed been demonstrated that an increase in
extracellular glucose from 0 to 20 mM provokes a 3.3 fold rise in
glucagon secretion evokedbya train ofdepolarizations inisolateda-
cells [26]. Moreover, Andersson et al. [27] have recently used
Model for Glucagon Secretion
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vicinity to the plasma membrane is larger at high glucose than at
low glucose. As the molecular mechanism by which external glucose
activates granule resupply is far from being fully elucidated, and
since we have data recorded at two glucose concentrations, we
simply assume in the model that the rate of resupply is a linear
function of extracellular glucose. Thus, the rate of change of the







with r1(½G )~m½G zb:
ð1Þ
In this equation, ½Ca2z c represents the concentration of Ca2z
in the cytosol, KD, the value of ½Ca2z c leading to half activation
of resupply by Ca2z , r{1, the rate constant characterizing the
transition of primed granules to the reserve one, P0, the number of
granules in the primed state without bound Ca2z , and r1, the
resupply rate at infinite Ca2z concentration. The dependence of
this rate on the external glucose concentration (½G ) is taken as a
linear function characterized by parameters m and b. The term r0
stands for the rate of granule formation. This term needs to be
included in the model in order to allow for the existence of a
steady state. Further steps represent Ca2z binding on docked
granules. These reversible binding reactions are described by the
mass action law. Thus,
Figure 1. Four experimental Ca2z oscillations from a-cells in intact islets. Islets are perfused with a solution containing 0.5 mM glucose for
the first 10 minutes, and then, solution is changed to one containing 11 mM glucose for the following 15 minutes. Oscillations, triggered by low
glucose concentrations, are highly irregular. The level of Ca2z is indicated in arbitrary fluorescence units.
doi:10.1371/journal.pone.0032282.g001
Figure 2. Stages proposed for glucagon secretion. Granules coming from the Reserve pool (R) resupply the Primed pool (P0) and then, upon
binding 3 Ca2z ions, granules become Fused (pool F). The Releasable stage includes all primed granules with 0 to 3 bound Ca2z . r1 and r{1 are the
forward and backward resupply rates, respectively. kon and koff are the binding and unbinding rates, respectively, associated to the Ca2z -sensor. c
stands for the fusion rate that manages the last non-reversible step of exocytosis. r0 and rF represent the rates of granules formation and granule
release, respectively.
doi:10.1371/journal.pone.0032282.g002
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In equations (2)–(6), ½Ca2z m represents the concentration of
Ca2z just beneath the plasma membrane, where granules are
docked; kon and koff stand for the rates of Ca2z binding and
dissociation, respectively; and c is the rate constant for granule
fusion. There might be a delay between fusion and glucagon
release, as found for insulin secretion [23]. This delay is introduced
through the rFF term, which is also necessary to get a steady state
in the model, as r0. In the Results section, accumulated secretion




Since experimentally obtained oscillations reflect cytoplasmic
Ca2z concentration (½Ca2z c), we estimated the corresponding
dynamic values for the local Ca2z concentration just below the a-
cell membrane (½Ca2z m). In b-cells, it has been suggested than
secretory granules are exposed to very high levels of local calcium
(up to 10 times higher than in the cytosol) [28]. No data are
available for a-cells probably due to the small size of these cells.
Thus, considering that granule diameter is between 260 and
290 nm [19] and, that granules are located just below the plasma
membrane [7], we performed simulations to estimate local ½Ca2z i
beneath the plasma membrane. We used our previously published
model that estimates intracellular Ca2z in concentric layers of
specific thickness for a spherical cell considering buffered diffusion
[29]; to this model, we added a Ca2z -extrusion pump [30] and a
compensating leak flux. Leak flux was adjusted to obtain a steady-
state ½Ca2z i close to 0.1 mM. Assuming that an a-cell could be
approximated by a spherical cell of 5.3 mm radius [19] with a large
nucleus (60% of the cytoplasm), we obtained that ½Ca2z m to
½Ca2z c ratio ranges between 1.26 to 1.29 depending on the
spatial extent considered for the layer beneath the membrane
(from 10 to 300 nm). For all subsequent simulations we have taken
100 nm, for which the ratio equals 1.28. Parameter values used to
estimate membrane Ca2z concentration (½Ca2z m) are given in
Table 1.
Parameter estimation
Using Ca2z concentrations recorded at 0:5G and 11G as inputs
to the secretion model, we estimate the adequate values for
parameters KD, m, b, r{1, r0, kon, koff, c and rF. We took as
starting points those values used in previously developed models
for secretion in chromaffin cells [25] and in pancreatic b-cells [5],
and adapted them using two different constraints:
1. To reproduce steady-state values of both the total number of granules and
the basal secretion rate. Total number of granules for each a-cell
(*5800) was estimated taking a mean cell radius of 5.3 mm
[19], that gives an average a-cell volume of 623.6 mm3, and
considering a granule density of 9.3 granules/mm3 [19]. This
granule population is in the range of the 4400 granules
observed by [27]. Basal secretion rate at high glucose (10 mM)
has been estimated in 16 to 20 pg/islet/hr (0.25 to 0.33 pg/
islet/min) [7,8]. These data were used to fix parameters r0 and
rF.
2. To predict the experimentally reported secretion in response to Ca2z
oscillations monitored in a-cells of mice, in the presence of low glucose. At
low glucose (0.5 and 1 mM), secretion is in the range 30–
60 pg/islet/hr (equivalent to 0.15–0.30 pg/cell/hr) [7–10],
which is twice the secretion rate at high glucose. To reproduce
this rate, we fitted parameters m, b, r{1 and c.
The remaining parameters (KD,kon,koff) were taken from the
literature [5,25]. Fitting was performed manually. It was tested
that results are not sensitive to slight variations of the parameter
values. The final set of parameter values as well as those values
used to quantify secretion are shown in Table 2. The granule
equivalence in femtograms (fg) was obtained considering that one
Table 1. Parameters to estimate membrane Ca2z
concentration.
Parameter Value Source
Cell radius 5.3 mm [19]
Layer thickness 100 nm Chosen
Endogenous buffer 500 mM with Kd =10mM [30]
Ca2z -extrusion pump 2 pmol=(cm2s) with
Kd =0.83 mM
[30]
Leak flux 21.9 mM/s Fitted
doi:10.1371/journal.pone.0032282.t001
Table 2. Parameters used to simulate secretion dynamics.
Parameter Value Reference
Secretion model
Glucose function m=3; b=18.5 Fitted
Glucose concentration G =0.5 and 11 mM Experiments
Ca2z affinity of resupply KD =2.3mM CC [25], bC [5]
Backward resupply rate r{1 =2.1s{1 Fitted
Ca2z -binding rate kon =0.5mM{1s{1 CC [25]
Ca2z -dissociation rate koff =4s{1 CC[25]
Fusion rate c=0.011 s{1 Fitted
Granule formation rate r0 =0.0001 s{1 Fitted
Granule release rate rF =0.01 s{1 Fitted
Other values
Cellular volume 623.6 mm3 Computed
Granule density 9.3 granules mm{3 aC[ 1 9 ]
Granule equivalence 2 fg Computed
CC=chromaffin cells, bC=b-cells, aC=a-cells.
doi:10.1371/journal.pone.0032282.t002
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PLoS ONE | www.plosone.org 4 March 2012 | Volume 7 | Issue 3 | e32282islet contains about 2 nanograms of glucagon [31] and a minimum
of 200 a-cells [2], so each cell contains, at most, 10 picograms of
glucagon. Considering that an a-cell possesses 5800 granules, the
granule content would be 1.72 fg of glucagon, then for simulations,
we are taking a round value of 2 fg per granule.
Simulations
Thepurpose ofthe secretionmodelisto quantitativelypredict the
level of glucagon secretion induced by real Ca2z oscillations in a-
cells from intact islets at different conditions. Two sets of Ca2z data
were supplied from experiments: One set was composed of 14
records (14 a-cells) coming from 3 islets going from 0.5 mM to
11 mM glucose, and the other set was made of 23 records (23 a-
cells) coming from 3 other islets at 0.5 mM glucose, with and
without exogenous insulin (4 nM). These records of Ca2z
oscillations are in arbitrary fluorescence units so, to fit parameters
in molar units, we seek for a reliable equivalence. Our data have not
beencalibratedbutwe simply compared them to thosemeasured by
other groups using similar techniques [13,15]. We indeed mainly
focus on the Ca2z dynamics for which accurate calibrations of the
absolute Ca2z levels are not necessary. We thus assume that one
fluorescent unit approximately corresponds to two nanoMolar units
of ½Ca2z i . On the basis of this empirical procedure, the values of
cytoplasmic calcium range between 30 to 400 nM, in agreement
with values reported in the works mentioned above.
Experimental Ca2z data were used as input to the secretion
model defined by equations (2)–(6). These simulations correspond
to the dynamics of secretion during either 20 minutes or 1 hour.
In both types of simulations, secretion computed for each cell was
shown as the individual secretion rate, and the predicted average
secretion rate was calculated as the average of all cells in an islet.
On the one hand, the 20-minute simulations were performed using
the experimental Ca2z records, taking 10 minutes in one
condition (low glucose) followed by 10 minutes in the other
condition (high glucose or presence of insulin). These dynamic
simulations brought out differences between individual and
average (islet) responses. Moreover, these simulations were also
useful to appreciate the time needed to reach a steady-state
response. On the other hand, one-hour simulations used as inputs
the same 10-minute records repeated six times. This methodology
was thought to make comparable predictions of glucagon
secretion, since in experiments accumulated secretion is generally
reported as pico- or femtograms per islet in one hour.
To illustrate the applicability of the model as a predictive tool,
we have studied the effect of insulin on glucagon secretion by
performing the same kind of simulations (20-minute and one-hour)
using experimental Ca2z records. These simulations allowed us to
compare the individual and the islet response to insulin and
glucose. Our hypothesis was to explore if the experimentally
reported effect of insulin on glucagon secretion may be entirely
Figure 3. Example of Ca2z and secretion dynamics in a 20-minute period, going from low (0:5G) to high glucose (11G). The Ca2z time-
series are shown in arbitrary units (top), while simulated individual (middle) and average (bottom) secretion rates are in fg per cell per minute.
Secretion is computed as the numerical integral of F(t)dt, taking into account that 1 granule corresponds to 2 fg of glucagon. Notice that individual
and average secretory responses have the same trends. All individual responses to low and high glucose are summarized in Figure 4.
doi:10.1371/journal.pone.0032282.g003
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islet Ca2z levels.
All simulations were performed using the parameter values
listed in Table 2.
Results
Dynamics of secretion induced by low- and high-glucose
periods
In Figure 3 we show an example of a dynamic simulation of
secretion obtained with the secretion model defined by equations
(1)–(6). The top panel shows the Ca2z time series used as input to
the model, the middle panel shows the individual secretion
induced by this Ca2z time series, and the bottom panel represents
the average secretion of the 14 cells. Cytoplasmic Ca2z
oscillations induce a secretion rate per minute that seems to have
a delayed maximal response to low glucose, as reported in [7].
This delay corresponds to the time needed by granules to become
releasable, as about half granules are in the reserve pool at resting
Ca2z . As expected, steady-state (after five minutes) secretion rate
at low-glucose is greater than at high-glucose for the whole set of
cells.
Steady state distribution of granules
We have estimated the population of releasable granules at
steady-state for both glucose conditions; this population includes
all primed granules belonging to the releasable stage considered in
our model (Figure 2). The population predicted by the model, at
high-glucose, was 49% in the Primed pool (P0) plus 3% in the +1
Ca2z pool (P1). The resultant percentage (52%) compares well
with the 55% found as the population of submembrane granules
located in the first 300 nm below the plasma membrane in [7],
suggesting that releasable granules in non-stimulated alpha cells
would be located between this distance as in neuroendocrine cells
[22]. In contrast, the model predicts that at low-glucose, 28% of
granules are in the Primed pool (P0) and 2% are in the +1 Ca2z
pool (P1), giving 30% of releasable granules. In both cases, the
predicted populations for P1 match well with estimations of the
readily-releasable pool (RRP)i na-cells (1 to 2%) [19,28], which
are larger than in b-cells (0.2 to 1%) [23]. Moreover, our
predictions are in good agreement with the reported observation
that there are more docked granules at high glucose conditions
than at low glucose [27]. On the other hand, having a larger
releasable pool at high glucose is supported by the fact that under
this condition, ATP levels should be higher so the priming step is
favored since it is ATP-dependent, as considered for b-cells [23].
High-glucose and low-glucose secretion in one hour
Individual secretion rates induced by each of the 14 Ca2z time-
series at 11G and 0:5G were predicted using one-hour files, as
explained in the Methods section. Then, mean secretion of the
ensemble in one hour was calculated to compare it to experimental
secretion. In Figure 4(A), we show the resulting individual
secretion rate per hour at 0:5G (blue dots) and 11G (red triangles),
as well as the average of all cells for low (0.242 pg/cell/hour, blue
line) and high (0.103 pg/cell/hour, red line) glucose. These values
indicate a high-glucose-induced reduction in secretion of 57%.
Accumulated secretions in 1 hour predicted by the model are 20.6
and 48.3 pg/islet at high and low glucose concentrations,
respectively, taking 200 a-cells per islet; these accumulated values
are in the range of experimental measurements [7,8,10,32]. From
this figure, we also predict that eight cells out of 14 (57%) clearly
secrete more glucagon at 0:5G than at 11G, 5 cells (36%) secrete
almost equal at both levels, and one cell (7%) secretes more
glucagon at 11G than at 0:5G (see Table 3). These results agree
with reported ideas that a-cells work in an asynchronous manner,
Figure 4. Individual cell secretion rates induced by Ca2z oscillations (A), and by constant Ca2z levels (B). The constant levels used for
simulations correspond to the individual mean values of Ca2z oscillations. Secretion rates in pg per cell per hour predicted at 0:5G (dots) and 11G
(triangles) are shown. Secretion in one hour is computed as the numerical integral of F(t)dt, taking into account that 1 granule corresponds to 2 fg of
glucagon. Lines indicate average secretion rates of the ensemble at low (blue) and high glucose (red). In agreement with experimental
measurements, the model predicts that mean glucagon secretion is reduced at high glucose.
doi:10.1371/journal.pone.0032282.g004
Model for Glucagon Secretion
PLoS ONE | www.plosone.org 6 March 2012 | Volume 7 | Issue 3 | e32282and with the known unequal participation of each cell to whole-
islet glucagon secretion [24].
Secretion induced by constant Ca2z levels
InordertoexploretheimpactofintracellularCa2z oscillationson
glucagonsecretionfromatheoreticalpointofview,wealsotestedthe
secretion predicted by our model for a constant Ca2z level equal to
the mean value obtained for each cell at a given glucose
concentration. This question is physiologically relevant given that
only 30% of total islet a-cells exhibit oscillating calcium levels [13].
The effect of an oscillatory Ca2z dynamics on various cellular
responses has indeed been studied by modeling in other cell types.
For example, it was predicted that Ca2z oscillations in liver cells can
potentiateglycogenolysisinresponsetolowlevelsofstimulation[33].
In other systems, where Ca2z -calmodulin kinase II is involved, the
level of physiological response is encoded in the frequency of Ca2z
oscillations [34]. In this sense, results about frequency, shown in next
section, aim at testing if such type of potentiation is present in a-cells.
In Figure 4(B) we show the individual secretion rates obtained for
mean Ca2z levels. In this case, the predictions of the model are:
seven cells out of fourteen (50%) clearly secrete more glucagon at
0:5G than at 11G, five cells (36%) secrete almost equal at both
levels, and two cells (14%) secrete more glucagon at 11G than at
0:5G. Moreover, average secretion rate at low glucose (0.198 pg/
cell/hr) is still above the rate at high glucose (0.093 pg/cell/hr), i.e.
there is still 53% of high-glucose-induced reduction on secretion. In
contrast, for low glucose concentration -which most of the time
induce Ca2z oscillations- the secretion rate is higher for an
oscillatory Ca2z signal (0.241 pg/cell/hour) than for a constant
Ca2z signal with the same average (0.198 pg/cell/hour); that is,
oscillations induce 21% more secretion. Moreover, the distribution
of individual participation in total islet release is different for a
constant than for an oscillatory calcium level, as summarized in
Table3.Themodelthuspredictsthatuponlow-glucosestimulation,
a-cells that display Ca2z oscillations secrete more glucagon than
those exhibiting a steady increase in Ca2z with the same average.
Effect of oscillation frequency and mean Ca2z levels on
secretion
The results shown in the preceding sections point toward the
fact that oscillations favor secretion. To understand the reasons of
this increase, we have first investigated the relationship between
glucagon secretion and the frequency of Ca2z oscillations.
Frequencies are between 0.3 to 1.6 per minute at 0.5 mM glucose,
with a mean value of 0.87 per minute, as in previous experiments
[16]. However, we found no correlation between secretion rate
and frequency (not shown). This suggests the absence of frequency
coding, which could be expected given the high level of irregularity
Table 3. Distribution of individual a-cell secretion.
Percentage of
cells
Ca2z dynamics 0:5Gw11G 0:5G~11G 11Gw0:5G
Oscillations 57% 36% 7%
Constant 50% 36% 14%
doi:10.1371/journal.pone.0032282.t003
Figure 5. Cell secretion rates as a function of individual mean Ca2z level. Secretion rates are plotted against the mean Ca2z level of each
cell, for different experimental and simulated conditions (see plot legend). Secretion in one hour is computed as the numerical integral of F(t)dt,
taking into account that 1 granule corresponds to 2 fg of glucagon. Best-fit curves for data sets are power functions with correlation coefficients
w0.9. Notice that for a given value of individual mean Ca2z , the presence of low glucose (dots) induces a lower secretion rate than the high glucose
(triangles), because of the glucose-dependence of granule resupply. The inset shows the behaviour of secretion rates at the lowest Ca2z range,
indicating that for a mean Ca2z level of 0.1 mM, the model predicts a basal rate about 0.1 pg/cell/hr (20–40 pg/islet/hr) in agreement with
experimental observations [7–10].
doi:10.1371/journal.pone.0032282.g005
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rates of secretion are shown as a function of individual mean Ca2z
level, considered as constant throughout the simulation. Red
triangles and blue dots indicate secretion rates obtained with
constant Ca2z levels corresponding to experimental records at
11G and 0:5G, respectively. We also represent in this figure
secretion rates obtained at arbitrary Ca2z concentrations (red
upward triangles), and at concentrations measured in the presence
of insulin (green squares) as discussed in next section. The curves
obtained at high and low glucose are different because resupply
depends on glucose concentration, hence the secretion rates.
Interestingly, these curves are steep, which provides a clue to
understand why oscillations favor secretion. Indeed, because of
this highly non-linear relationship between mean Ca2z and
secretion rate, a small increase in Ca2z concentration produces a
large increase in secretion rate; thus, average secretion during
oscillations is larger than the secretion obtained over the same
period of time with constant Ca2z . Such a type of oscillation-
induced potentiation of a Ca2z -activated response, has been
demonstrated experimentally for gene expression [35].
Prediction of glucagon secretion in the presence of
insulin
It is indeed known that in physiological conditions, insulin and
glucose both modulate glucagon release in a-cells, although the
mechanisms involved in this regulation are still under debate [11].
Insulin inhibits glucagon secretion, but this inhibition remains
poorly understood [36]. In Figure 6 we show a dynamic simulation
for these conditions, where the top panel shows the Ca2z time
series used as input to the model, the middle panel shows the
individual secretion induced by this Ca2z time series, and the
bottom panel represents the average secretion of the 23 cells. For
these new simulations, we found an average secretion rate at 0:5G
of 0.435 pg/cell/hour, different than the value obtained with the
previous set of Ca2z data in the same conditions (0.241 pg/cell/
hour). However, this difference is of the order of variability in
secretion among different islets (see Figure 7(B)). In the presence of
insulin the model predicts that average secretion falls to 0.313 pg/
cell/hour. This predicted 30% reduction is in the order of
previously reported insulin-induced inhibitions at low glucose, for
different concentrations of insulin (17 to 100 nM) [1,26]. Then,
from our results at low glucose, glucagon inhibition due to 4 nM
insulin is smaller than to high glucose. However, it is probable that
higher insulin concentrations would be more potent.
In Figure 7(A) we show the mean Ca2z levels managed by each
of the six islets that have been considered in the present study (3
islets under low and high glucose, and 3 islets under low glucose
with and without insulin); all these Ca2z values are computed
from experimental records. In Figure 7(B) we compare the
inhibition of secretion induced by glucose elevation and by insulin.
Figure 6. Example of Ca2z and secretion dynamics in a 20-minute period at low glucose (0:5G), before and after the addition of
4 nM insulin. The Ca2z time-series in arbitrary units (top), as well as the simulated individual (middle) and average (bottom) secretion rates are
shown in fg per cell per minute. Secretion is computed as the numerical integral of F(t)dt, taking into account that 1 granule corresponds to 2 fg of
glucagon. Notice that individual and average secretory responses have the same trends.
doi:10.1371/journal.pone.0032282.g006
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secretion, and that this effect is associated to a reduction of the islet
Ca2z level; then, a smaller Ca2z reduction induces a smaller
inhibition, as in the presence of insulin. These plots also point out
the high non-linearity between Ca2z levels and secretion in islets,
as found for individual cells (Figure 5). We also notice an islet
regularity, due to glucose or insulin, which contrasts with cell to
cell variability.
Discussion
In this study, we have developed a simple model that
quantitatively reproduces the rates of glucagon secretion by a-
cells undergoing glucose-induced Ca2z changes. We found that,
although Ca2z oscillations are highly variable, the average
secretion rates predicted by the model fall into the range of values
reported in the literature both for high and low glucose. Moreover,
the model leads to interesting hypotheses concerning the
molecular mechanisms that govern and regulate glucagon release.
In particular, the model predicts that, in contrast to chromaffin
cells, just one type of releasable granules could manage glucose-
induced glucagon secretion in a-cells. Besides that, the secretory
process is very similar in both cell types, involving three steps of
Ca2z binding, with similar affinities. In agreement with this, a low
affinity Ca2z -sensing protein (known as synaptotagmin) mediates
the fusion of the secretory granules to the plasma membrane in
both cell types [7,22]. This is similar to pancreatic b-cells as well
[23].
Our modeling approach, however, emphasizes the importance
of a specific regulation of secretion in a-cells. The model indeed
takes into account that the resupply of releasable granules is not
only controlled by cytoplasmic calcium, as in neuroendocrine and
b-cells, but also by the level of extracellular glucose [26]. Here, we
assume that resupply rate has a linear dependence on glucose
concentration (r1(½G )), which leads to a good agreement for both
secretion rate and granule distribution at high and low glucose
concentrations. Taking into account the maximal resupply rate
estimated for mouse a-cells under depolarization-induced exocy-
tosis (20 granules per second) [19], the model indeed predicts the
observed steady-state secretion rate at low glucose reported in [7]
(i.e. 0.8 to 1 pg/islet/minute). Moreover, the proposed linear
function for glucose sensitivity of resupply also leads to a good
estimation of granule mobilization for stimulated (low-glucose)
conditions, as the resupply rate is increased about 2.5-fold for high
glucose (up to 51.5 granules per second), which agrees with the
3.3-fold reported in [26] although this was observed for rat a-cells.
Our results indicate that glucose may regulate glucagon
secretion through two different and counter-acting actions in a-
cells. On the one hand, low glucose stimulates calcium oscillations
that induce and potentiate glucagon release. On the other hand,
low glucose reduces the rate of granule resupply. Our physiological
interpretation of this apparent paradox is that during low glucose
periods, there would be a well-controlled number of releasable
granules refilled slowly from a huge reserve pool to ensure a
steady-state secretion rate that could last for several minutes (as
observed by [7]). This would be reasonable to avoid that a-cells
would exhaust the releasable pool of granules, and could mean
also that the a-cell has its own glucose-sensing mechanisms as
discussed in some works [1,9].
About the effect of insulin in islets at low glucose, we have
observed a reduction of the mean Ca2z level in each islet
(Figure 7(A)), which is responsible for the decrease in glucagon
secretion predicted by the model (Figure 7(B)). With the insulin
concentration used in the present study (4 nM) at low glucose,
Figure 7. Effect of insulin and high glucose on mean Ca2z level and glucagon secretion for the six studied islets. (A) Reduction of the
mean Ca2z level due to the elevation of glucose in islets 1–3 (blue and red bars in the left), compared to the reduction induced by insulin at low
glucose in islets 4–6 (blue and green bars in the right). Average Ca2z levels are indicated with dashed lines. (B) Glucagon inhibition induced by
increasing extracellular glucose in islets 1–3 (blue and red bars in the left), compared to the inhibition induced by the presence of insulin in islets 4–6
(blue and green bars in the right). Secretion is normalized to the largest value to emphasize differences. Average secretions are marked with dashed
lines.
doi:10.1371/journal.pone.0032282.g007
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inhibition induced by high glucose. In the pancreas, glucose has an
inhibitory effect by itself but at the same time, it can activate other
inhibitory processes from b-cells such as insulin secretion [11].
Our study suggests that insulin and glucose both reduce glucagon
release by lowering intracellular Ca2z in a-cells. Therefore, we
cannot exclude that in experiments performed on intact islets, a
high concentration of glucose in the extracellular solution can
induce some insulin secretion; glucose elevation may thus
modulate glucagon secretion both directly and through insulin,
leading to a stronger inhibition.
Overall, the present results emphasize the main role played by
Ca2z and glucose in the control of glucagon secretion by a-cells.
Glucose control is occurring both via a direct pathway that affects
the resupply of secretory granules and via a control of Ca2z
dynamics, while insulin is only modulating intracellular Ca2z
dynamics. The cellular mechanisms and specific pathways
involved in both regulations need to be unveiled. As other
previous studies [33,35], our modeling approach of glucose-
induced glucagon secretion in a-cells also enlightens the
potentiating role of Ca2z oscillations versus constant levels with
the same average, as summarized in Table 3. Thus, at low glucose
concentrations, whole-islet glucagon secretion may be elevated not
only by a higher average Ca2z in each a-cell, but also by the
release increment induced by a-cells exhibiting Ca2z oscillations.
Such an observation suggests new therapeutic targets as the level
of secretion might be manipulated by drugs affecting both the
levels and the dynamics of Ca2z increases.
We conclude that under normal functioning, the a-cell would be
able to respond for long hypoglycemic periods as speculated in
some works [28], but under pathological conditions as in diabetic
patients, it may be unable to maintain the constant secretion rate
probably due to abnormal blood glucose levels that would affect
granule mobilization, and would induce insulin secretion leading
to reduced islet Ca2z levels. In the near future, this model could
also be implemented to simulate and/or predict calcium signals
and glucagon release by pancreatic a-cells in pathological
situations such as type 1 diabetes, which is characterized by a
lack or very low concentrations of insulin and elevated glucose
levels. Other pathological situations, such as insulin resistance and
hyperinsulinemia that take place during the onset of type 2
diabetes could be also modeled.
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